| 768368 |
FRONTIERS IN ONCOLOGY |
Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints |
2021-11-11 |
10.3389/fonc.2021.759015 |
Xu Yaolin, He Lijie, Fu Qiang, Hu Junzhe |
| 768367 |
FRONTIERS IN ONCOLOGY |
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia |
2021-11-11 |
10.3389/fonc.2021.756348 |
Fontana Diletta, Gambacorti-Passerini Carlo, Piazza Rocco |
| 768366 |
FRONTIERS IN ONCOLOGY |
Preliminary Safety and Efficacy of Proton Plus Carbon-Ion Radiotherapy With Concurrent Chemotherapy in Limited-Stage Small Cell Lung Cancer |
2021-11-11 |
10.3389/fonc.2021.766822 |
Ma Ning-Yi, Chen Jian, Ming Xue, Jiang Guo-Liang, Lu Jiade J., Wu Kai-Liang, Mao Jingfang |
| 768365 |
FRONTIERS IN ONCOLOGY |
HK2 Is a Crucial Downstream Regulator of miR-148a for the Maintenance of Sphere-Forming Property and Cisplatin Resistance in Cervical Cancer Cells |
2021-11-11 |
10.3389/fonc.2021.794015 |
Yang Hao, Hou Hui, Zhao Haiping, Yu Tianwei, Hu Yuchong, Hu Yue, Guo Junmei |
| 768364 |
FRONTIERS IN ONCOLOGY |
The Clinical Significance and Transcription Regulation of a DNA Damage Repair Gene, SMC4, in Low-Grade Glioma via Integrated Bioinformatic Analysis |
2021-11-11 |
10.3389/fonc.2021.761693 |
Wang Yan, Wu Zhisheng |
| 768363 |
FRONTIERS IN ONCOLOGY |
Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management |
2021-11-11 |
10.3389/fonc.2021.758958 |
Kuyumcu Serkan, Sanli Yasemin, Subramaniam Rathan M. |
| 768362 |
FRONTIERS IN ONCOLOGY |
Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review |
2021-11-11 |
10.3389/fonc.2021.748444 |
Johnson Ben William, Takahashi Ken, Cheng Yuen Yee |
| 768361 |
FRONTIERS IN ONCOLOGY |
Understanding Monoclonal B Cell Lymphocytosis: An Interplay of Genetic and Microenvironmental Factors |
2021-11-11 |
10.3389/fonc.2021.769612 |
Galigalidou Chrysi, Zaragoza-Infante Laura, Iatrou Anastasia, Chatzidimitriou Anastasia, Stamatopoulos Kostas, Agathangelidis Andreas |
| 768360 |
FRONTIERS IN ONCOLOGY |
The Hippo Signaling Pathway: The Trader of Tumor Microenvironment |
2021-11-11 |
10.3389/fonc.2021.772134 |
Yang Duo, Zhang Na, Li Meihua, Hong Tao, Meng Wei, Ouyang Taohui |
| 768359 |
FRONTIERS IN ONCOLOGY |
The Integration of the Pre-Treatment Neutrophil-to-Lymphocyte Ratio in the Eighth Edition of the AJCC Staging System for Nasopharynx Cancer |
2021-11-11 |
10.3389/fonc.2021.724467 |
Liang Zhong-Guo, Zhang Fan, Li Ye, Li Ling, Qu Song, Su Fang, Yu Bin-Bin, Guan Ying, Han Lu, Li Kai-Guo, Zhu Xiao-Dong |
